Blindspots
Member
Moderna vaccine remains 93% effective against symptomatic COVID at 6 months, company says
Data collected prior to delta variant's emergence in US
Moderna says its vaccine is 93% effective against symptomatic illness at six months (though this data collection ended before delta emerged in the U.S.).
Moderna said its booster candidates also demonstrate robust antibody responses to variants of concern, including delta.
Company President Dr. Stephen Hoge told "Good Morning America" Thursday that the Moderna vaccine offers protection from delta right after receiving it, but it's not known yet if that'll hold up through the winter. He called winter "the biggest test of that vaccine which is why we need to be vigilant and careful."
Data collected prior to delta variant's emergence in US
Moderna says its vaccine is 93% effective against symptomatic illness at six months (though this data collection ended before delta emerged in the U.S.).
Moderna said its booster candidates also demonstrate robust antibody responses to variants of concern, including delta.
Company President Dr. Stephen Hoge told "Good Morning America" Thursday that the Moderna vaccine offers protection from delta right after receiving it, but it's not known yet if that'll hold up through the winter. He called winter "the biggest test of that vaccine which is why we need to be vigilant and careful."